315
Views
8
CrossRef citations to date
0
Altmetric
Articles

Synthesis of 2′-deoxy-2′-fluoro-2′-C-methyl spiro cyclopentyl carbocyclic uridine analog as potential inhibitors of HCV NS5B polymerase

ORCID Icon & ORCID Icon
Pages 52-68 | Received 11 Nov 2019, Accepted 20 Nov 2019, Published online: 20 Apr 2020

References

  • Chevaliez, S.; Pawlotsky, J. M. HCV Genome and Life Cycle. In Hepatitis C Viruses: Genomes and Molecular Biology, Tan, S. L., Ed. Horizon Bioscience: Norfolk (UK), 2006.
  • https://www.who.int/news-room/fact-sheets/detail/hepatitis-c.
  • Palumbo, E. Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection. Ther. Adv. Chronic Dis 2011, 2, 39–45. DOI: 10.1177/2040622310384308.
  • Gentile, I.; Maraolo, A. E.; Buonomo, A. R.; Zappulo, E.; Borgia, G. The Discovery of Sofosbuvir: A Revolution for Therapy of Chronic Hepatitis C. Expert Opin. Drug Discov. 2015, 10, 1363–1377. DOI: 10.1517/17460441.2015.1094051.
  • Sofia, M. J.; Bao, D.; Chang, W.; Du, J. F.; Nagarathnam, D.; Rachakonda, S.; Reddy, P. G.; Ross, B. S.; Wang, P. Y.; Zhang, H. R.; et al. Discovery of a beta-D-2'-Deoxy-2'-Alpha-Fluoro-2'-beta-C-Methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus. J. Med. Chem. 2010, 53, 7202–7218. DOI: 10.1021/jm100863x.
  • Jonckers, T. H. M.; Lin, T.-I.; Buyck, C.; Lachau-Durand, S.; Vandyck, K.; Van Hoof, S.; Vandekerckhove, L. A. M.; Hu, L.; Berke, J. M.; Vijgen, L.; et al. 2'-Deoxy-2'-Spirocyclopropylcytidine Revisited: A New and Selective Inhibitor of the Hepatitis C Virus NS5B Polymerase. J. Med. Chem. 2010, 53, 8150–8160. DOI: 10.1021/jm101050a.
  • Bessieres, M.; Chevrier, F.; Roy, V.; Agrofoglio, L. A. Recent Progress for the Synthesis of Selected Carbocyclic Nucleosides. Future Med. Chem. 2015, 7, 1809–1828. DOI: 10.4155/fmc.15.105.
  • Rawal, R. K.; Singh, U. S.; Chavre, S. N.; Wang, J. N.; Sugiyama, M.; Hung, W.; Govindarajan, R.; Korba, B.; Tanaka, Y.; Chu, C. K. 2'-Fluoro-6'-Methylene-Carbocyclic Adenosine Phosphoramidate (FMCAP) Prodrug: In Vitro anti-HBV Activity against the Lamivudine-Entecavir Resistant Triple Mutant and Its Mechanism of Action. Bioorg. Med. Chem. Lett. 2013, 23, 503–506.
  • Singh, U. S.; Mulamoottil, V. A.; Chu, C. K. 2'-Fluoro-6'-Methylene Carbocyclic Adenosine and Its Phosphoramidate Prodrug: A Novel anti-HBV Agent, Active against Drug-Resistant HBV Mutants. Med. Res. Rev. 2018, 38, 977–1002.
  • Gadthula, S.; Rawal, R. K.; Sharon, A.; Wu, D.; Korba, B.; Chu, C. K. Synthesis and Antiviral Activity of Cyclopropyl-Spirocarbocyclic Adenosine, (4R,5S,6R,7R)-4-(6-Amino-9H-Purin-9-yl)-7-(Hydroxymethyl)Spiro[2.4]Heptane-5,6-di ol against Hepatitis C Virus. Bioorg. Med. Chem. Lett. 2011, 21, 3982–3985. DOI: 10.1002/chin.201147198.
  • Singh, U. S.; Mishra, R. C.; Shankar, R.; Chu, C. K. Stereoselective Synthesis of 2'-Fluoro-6'-Methylene Carbocyclic Adenosine via Vince Lactam. J. Org. Chem. 2014, 79, 3917–3923. DOI: 10.1021/jo500382v.
  • Alcaraz, L.; Cridland, A.; Kinchin, E. Novel Conversion of 1,2-Disubstituted Cis-Epoxides to One-Carbon Homologated Allylic Alcohols Using Dimethylsulfonium Methylide. Org. Lett. 2001, 3, 4051–4053. DOI: 10.1021/ol016782y.
  • Singh, U. S.; Mulamoottil, V. A.; Chu, C. K. Synthesis of an anti-Hepatitis B Agent, 2'-Fluoro-6'-Methylene-Carbocyclic Adenosine (FMCA) and Its Phosphoramidate (FMCAP). J. Org. Chem. 2019, 84, 752–759. DOI: 10.1021/acs.joc.8b02599.
  • Simmons, H. E.; Smith, R. D. A New Synthesis of Cyclopropanes. J. Am. Chem. Soc. 1959, 81, 4256–4264. DOI: 10.1021/ja01525a036.
  • Omura, K.; Sharma, A. K.; Swern, D. Dimethyl Sulfoxide-Trifluoroacetic Anhydride - New Reagent for Oxidation of Alcohols to Carbonyls. J. Org. Chem. 1976, 41, 957–962. DOI: 10.1021/jo00868a012.
  • Hayakawa, H.; Tanaka, H.; Itoh, N.; Nakajima, M.; Miyasaka, T.; Yamaguchi, K.; Iitaka, Y. Reaction of Organometallic Reagents with 2'-Ketouridine and 3'-Ketouridine Derivatives - Synthesis of Uracil Nucleosides Branched at the 2'-Position and 3'-Position. Chem. Pharm. Bull. 1987, 35, 2605–2608. DOI: 10.1248/cpb.35.2605.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.